000			02306 a2200649 4500
005			20250515084203.0
264		0	_c20080116
008			200801s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdm347 _2doi
040			_aNLM _beng _cNLM
100	1		_aBajetta, E
245	0	0	_aCapecitabine plus oxaliplatin and irinotecan regimen every other week: a phase I/II study in first-line treatment of metastatic colorectal cancer. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cNov 2007
300			_a1810-6 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBiopsy, Needle
650	0	4	_aCamptothecin _xadministration & dosage
650	0	4	_aCapecitabine
650	0	4	_aColorectal Neoplasms _xdrug therapy
650	0	4	_aConfidence Intervals
650	0	4	_aDeoxycytidine _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aFluorouracil _xadministration & dosage
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aImmunohistochemistry
650	0	4	_aIrinotecan
650	0	4	_aLiver Neoplasms _xdrug therapy
650	0	4	_aMale
650	0	4	_aMaximum Tolerated Dose
650	0	4	_aNeoplasm Invasiveness _xpathology
650	0	4	_aNeoplasm Staging
650	0	4	_aOrganoplatinum Compounds _xadministration & dosage
650	0	4	_aOxaliplatin
650	0	4	_aRisk Assessment
650	0	4	_aSurvival Analysis
650	0	4	_aTreatment Outcome
700	1		_aCelio, L
700	1		_aFerrario, E
700	1		_aDi Bartolomeo, M
700	1		_aDenaro, A
700	1		_aDotti, K
700	1		_aMancin, M
700	1		_aBajetta, R
700	1		_aColombo, A
700	1		_aPusceddu, S
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 18 _gno. 11 _gp. 1810-6
856	4	0	_uhttps://doi.org/10.1093/annonc/mdm347 _zAvailable from publisher's website
999			_c17351789 _d17351789